Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EEC Skin Test for Tuberculosis Diagnosis
NCT06305104Phase 2Recruiting
- Sponsor
- Chengdu Coen Biotechnology
- Start
- Jul 2023
- Primary completion
- May 2024
- Modality
- rProtein (Recombinant Protein), Biologic (Biologic)
- Countries
- 1
01
Overview
A Phase 2 trial of EEC in Tuberculosis (TB), sponsored by Chengdu Coen Biotechnology. Started Jul 2023; status: recruiting.
02
Drugs
EEC
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT06305104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06305104.